|
31999.01.01
|
ABACAVIR+LAMIVUDINE/MYLAN PHARMA F.C.TAB (600+300)MG/TAB BT x 30 (30x1) TABS σε BLISTER (PVC/PVDC/AL)
|
|
90,51 |
104,04 |
127,93 |
Mylan Healthcare Ireland Ltd
|
|
32869.01.06
|
ABIRATERONE MYLAN F.C.TAB 500MG/TAB 60 ΔΙΣΚΙΑ ΣΕ BLISTERS (ALU-PVC/PE/PVDC)
|
|
1.359,86 |
1.512,44 |
1.663,31 |
Mylan Healthcare Ireland Ltd
|
|
32361.01.11
|
APIXABAN/MYLAN F.C.TAB 2.5MG/TAB BT X 60 X 1 TAB ΣΕ UNIT-DOSE ALU-PVC/PVDC BLISTER
|
|
29,97 |
34,45 |
47,48 |
Mylan Healthcare Ireland Ltd
|
|
32361.02.13
|
APIXABAN/MYLAN F.C.TAB 5MG/TAB BT X 60 X 1 TAB ΣΕ UNIT-DOSE ALU-PVC/PVDC BLISTER
|
|
29,99 |
34,47 |
47,50 |
Mylan Healthcare Ireland Ltd
|
|
25673.02.03
|
ARIXTRA INJ.SOL 1,5MG/0,3ML PF.SYR BTX10 PF.SYR.
|
|
22,34 |
25,67 |
35,37 |
Mylan Healthcare Ireland Ltd
|
|
25673.05.03
|
ARIXTRA INJ.SOL 10MG/0,8ML BTX10PF.SYR
|
|
103,51 |
118,98 |
146,30 |
Mylan Healthcare Ireland Ltd
|
|
25673.01.03
|
ARIXTRA INJ.SOL 2,5MG/0,5ML PF.SYR BTX10PF.SYR.
|
|
29,04 |
33,38 |
45,99 |
Mylan Healthcare Ireland Ltd
|
|
25673.04.03
|
ARIXTRA INJ.SOL 7,5MG/0,6ML BTX10PF.SYR
|
|
94,15 |
108,22 |
133,07 |
Mylan Healthcare Ireland Ltd
|
|
31502.01.06
|
ATORVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28
|
|
4,63 |
5,32 |
7,34 |
Mylan Healthcare Ireland Ltd
|
|
31502.02.06
|
ATORVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28
|
|
5,06 |
5,81 |
8,00 |
Mylan Healthcare Ireland Ltd
|
|
31502.03.06
|
ATORVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28
|
|
5,06 |
5,81 |
8,00 |
Mylan Healthcare Ireland Ltd
|
|
32409.01.01
|
AZACITIDINE MYLAN PD.INJ.SUS 25MG/ML 1 vial x 100 mg
|
|
135,41 |
155,65 |
188,09 |
Mylan Healthcare Ireland Ltd
|
|
31962.02.01
|
BORTEZOMIB/MYLAN PD.INJ.SOL 3.5MG/VIAL BT x 1 VIAL (6ML)x 1 MG
|
|
357,68 |
397,82 |
463,86 |
Mylan Healthcare Ireland Ltd
|
|
31035.02.03
|
CAPECITABINE/MYLAN F.C.TAB 500MG/TAB BTx1 tab x 120 blisters (Al/PVC/PE/PVDC)-unit dose
|
|
71,76 |
82,48 |
104,92 |
Mylan Healthcare Ireland Ltd
|
|
31014.02.03
|
CARVEDILOL/MYLAN F.C.TAB 12,5MG/TAB BTx28 (2 BLIST x14)
|
|
3,00 |
3,45 |
4,75 |
Mylan Healthcare Ireland Ltd
|
|
31014.03.03
|
CARVEDILOL/MYLAN F.C.TAB 25MG/TAB ΒΤx28 (2 BLIST x14)
|
|
3,34 |
3,84 |
5,29 |
Mylan Healthcare Ireland Ltd
|
|
31014.01.03
|
CARVEDILOL/MYLAN F.C.TAB 6,25MG/TAB BTx28 (2 BLIST x14)
|
|
1,42 |
1,64 |
2,26 |
Mylan Healthcare Ireland Ltd
|
|
33062.01.02
|
DIMETHYL FUMARATE MYLAN GR.CAP 120MG/CAP 14 X 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
50,65 |
58,22 |
74,05 |
Mylan Healthcare Ireland Ltd
|
|
33062.02.02
|
DIMETHYL FUMARATE MYLAN GR.CAP 240MG/CAP 56 X 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
379,47 |
422,05 |
487,63 |
Mylan Healthcare Ireland Ltd
|
|
31059.02.02
|
DONEPEZIL/MYLAN F.C.TAB 10MG/TAB BT x 28 (σε PVDC BLISTER) (σε PVDC BLISTER)
|
|
11,99 |
13,78 |
18,98 |
Mylan Healthcare Ireland Ltd
|
|
31059.01.03
|
DONEPEZIL/MYLAN F.C.TAB 5MG/TAB BT x 28 (σε PVDC BLISTER) (σε PVDC BLISTER)
|
|
8,99 |
10,33 |
14,24 |
Mylan Healthcare Ireland Ltd
|
|
31442.01.02
|
ERLOTINIB/MYLAN F.C.TAB 100MG/TAB BTx(30x1) tabs σε Aluminium - OPA/Alu/PVC berforated blisters unit dose
|
|
654,19 |
727,59 |
821,37 |
Mylan Healthcare Ireland Ltd
|
|
31368.01.02
|
ESCITALOPRAM/MYLAN F.C.TAB 10MG/TAB BT x 14 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
2,44 |
2,80 |
3,86 |
Mylan Healthcare Ireland Ltd
|
|
31368.01.05
|
ESCITALOPRAM/MYLAN F.C.TAB 10MG/TAB BT x 30 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
4,93 |
5,66 |
7,80 |
Mylan Healthcare Ireland Ltd
|
|
31368.02.02
|
ESCITALOPRAM/MYLAN F.C.TAB 20MG/TAB BT x 14 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
4,96 |
5,71 |
7,87 |
Mylan Healthcare Ireland Ltd
|
|
31368.02.05
|
ESCITALOPRAM/MYLAN F.C.TAB 20MG/TAB BT x 30 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
9,36 |
10,76 |
14,83 |
Mylan Healthcare Ireland Ltd
|
|
30761.01.06
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+10)MG/TAB BTx(28 x 1) tabs σε blister (unit dose)
|
|
12,98 |
14,92 |
20,56 |
Mylan Healthcare Ireland Ltd
|
|
30761.02.07
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+20)MG/TAB BTx(28 x 1) tabs ( PVC/PVDC-Alu blister-unit dose)
|
|
10,63 |
12,22 |
16,84 |
Mylan Healthcare Ireland Ltd
|
|
30761.03.07
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+40)MG/TAB BTx(28 x 1) tabs ( PVC/PVDC-Alu blister-unit dose)
|
|
11,22 |
12,89 |
17,77 |
Mylan Healthcare Ireland Ltd
|
|
32856.01.18
|
FINGOLIMOD MYLAN CAPS 0.5MG/CAP 28 ΚΑΨΑΚΙΑ - ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
643,68 |
715,90 |
808,18 |
Mylan Healthcare Ireland Ltd
|
|
31058.01.07
|
FLUOXETINE/MYLAN CAPS 20MG/CAP BTx28 (BLISTER)
|
|
4,53 |
5,20 |
7,17 |
Mylan Healthcare Ireland Ltd
|
|
30946.01.03
|
FUSIDIC ACID+BETAMETHASONE VALERATE/MYLAN CREAM (20+1)MG/G BTx30G
|
|
4,25 |
4,91 |
7,03 |
Mylan Healthcare Ireland Ltd
|
|
31405.01.02
|
GLATIRAMER/MYLAN INJ.SO.PFS 40MG/1ML PF.SYR. BTx12 (PF.SYR x1ML)
|
|
424,90 |
472,57 |
546,01 |
Mylan Healthcare Ireland Ltd
|
|
31192.01.03
|
IMATINIB/MYLAN F.C.TAB 100MG/TAB BTx60 (6x1) σε PVC/PE/PVDC/ALU PERFORATED UNIT-DOSE BLISTERS
|
|
162,09 |
186,31 |
225,13 |
Mylan Healthcare Ireland Ltd
|
|
31192.02.03
|
IMATINIB/MYLAN F.C.TAB 400MG/TAB BTx30 (30x1) σε PVC/PE/PVDC/ALU PERFORATED UNIT-DOSE BLISTERS
|
|
406,34 |
451,93 |
522,16 |
Mylan Healthcare Ireland Ltd
|
|
32640.04.02
|
LENALIDOMIDE MYLAN CAPS 10.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.711,39 |
1.903,42 |
2.083,20 |
Mylan Healthcare Ireland Ltd
|
|
32640.05.02
|
LENALIDOMIDE MYLAN CAPS 15.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.804,16 |
2.006,59 |
2.190,80 |
Mylan Healthcare Ireland Ltd
|
|
32640.01.03
|
LENALIDOMIDE MYLAN CAPS 2.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
875,45 |
973,68 |
1.088,86 |
Mylan Healthcare Ireland Ltd
|
|
32640.06.03
|
LENALIDOMIDE MYLAN CAPS 20.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
2.283,77 |
2.540,03 |
2.759,74 |
Mylan Healthcare Ireland Ltd
|
|
32640.07.03
|
LENALIDOMIDE MYLAN CAPS 25.0MG/CAP BT x 21 x 1καψάκια - μονάδα δλοσης σε BLISTERS PVC/ACLAR/ αλουμίνιο
|
|
2.113,73 |
2.350,90 |
2.560,48 |
Mylan Healthcare Ireland Ltd
|
|
32640.02.02
|
LENALIDOMIDE MYLAN CAPS 5.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.750,88 |
1.947,34 |
2.131,27 |
Mylan Healthcare Ireland Ltd
|
|
32640.03.03
|
LENALIDOMIDE MYLAN CAPS 7.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.283,54 |
1.427,57 |
1.577,53 |
Mylan Healthcare Ireland Ltd
|
|
31037.03.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (100+25+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,47 |
9,73 |
13,41 |
Mylan Healthcare Ireland Ltd
|
|
31037.04.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (125+31,25+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,02 |
9,22 |
12,71 |
Mylan Healthcare Ireland Ltd
|
|
31037.05.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (150+37,5+200)MG/TAB BTx30 (HDPE Bottle)
|
|
9,31 |
10,70 |
14,74 |
Mylan Healthcare Ireland Ltd
|
|
31037.06.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (200+50+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,61 |
9,89 |
13,63 |
Mylan Healthcare Ireland Ltd
|
|
31037.01.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (50+12.5+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,00 |
9,20 |
12,68 |
Mylan Healthcare Ireland Ltd
|
|
31037.02.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (75+18.75+200)MG/TAB BTx30 (HDPE Bottle)
|
|
9,16 |
10,53 |
14,51 |
Mylan Healthcare Ireland Ltd
|
|
31015.01.05
|
MIRTAZAPINE/MYLAN F.C.TAB 30MG/TAB BTx30 ΣΕ PVDC COATED PVC BLISTER STRIPS WITH ALUMINIUM FOIL LIDDING
|
|
4,94 |
5,68 |
7,82 |
Mylan Healthcare Ireland Ltd
|
|
31015.02.05
|
MIRTAZAPINE/MYLAN F.C.TAB 45MG/TAB BTx30 ΣΕ PVDC COATED PVC BLISTER STRIPS WITH ALUMINIUM FOIL LIDDING
|
|
6,54 |
7,52 |
10,37 |
Mylan Healthcare Ireland Ltd
|
|
31029.02.02
|
MOXONIDINE/MYLAN F.C.TAB 300MCG/TAB BTx 28 (σε BLISTERS)
|
|
3,56 |
4,09 |
5,64 |
Mylan Healthcare Ireland Ltd
|
|
31525.01.02
|
OLMEDIPIN F.C.TAB (20+5)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
5,86 |
6,73 |
9,28 |
Mylan Healthcare Ireland Ltd
|
|
31525.03.02
|
OLMEDIPIN F.C.TAB (40+10)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
6,45 |
7,42 |
10,23 |
Mylan Healthcare Ireland Ltd
|
|
31525.02.02
|
OLMEDIPIN F.C.TAB (40+5)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
5,96 |
6,85 |
9,44 |
Mylan Healthcare Ireland Ltd
|
|
32043.01.01
|
OLMEDIPIN PLUS F.C.TAB (20+5+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
6,96 |
8,00 |
11,02 |
Mylan Healthcare Ireland Ltd
|
|
32043.04.01
|
OLMEDIPIN PLUS F.C.TAB (40+10+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
6,86 |
7,89 |
10,88 |
Mylan Healthcare Ireland Ltd
|
|
32043.05.01
|
OLMEDIPIN PLUS F.C.TAB (40+10+25.0)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
6,99 |
8,04 |
11,08 |
Mylan Healthcare Ireland Ltd
|
|
32043.02.01
|
OLMEDIPIN PLUS F.C.TAB (40+5+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
6,96 |
8,00 |
11,02 |
Mylan Healthcare Ireland Ltd
|
|
32043.03.01
|
OLMEDIPIN PLUS F.C.TAB (40+5+25.0)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,07 |
8,13 |
11,20 |
Mylan Healthcare Ireland Ltd
|
|
30576.01.02
|
OLMESARTAN/MYLAN F.C.TAB 10MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
3,59 |
4,12 |
5,68 |
Mylan Healthcare Ireland Ltd
|
|
30576.02.02
|
OLMESARTAN/MYLAN F.C.TAB 20MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
3,84 |
4,42 |
6,10 |
Mylan Healthcare Ireland Ltd
|
|
30576.03.02
|
OLMESARTAN/MYLAN F.C.TAB 40MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
4,05 |
4,66 |
6,42 |
Mylan Healthcare Ireland Ltd
|
|
32143.01.02
|
PEMETREXED/MYLAN C/S.SOL.IN 25MG/ML 1 Vial x20 ml
|
|
359,72 |
400,08 |
462,26 |
Mylan Healthcare Ireland Ltd
|
|
32143.01.01
|
PEMETREXED/MYLAN C/S.SOL.IN 25MG/ML 1Vial x 4ML
|
|
77,38 |
88,94 |
113,13 |
Mylan Healthcare Ireland Ltd
|
|
32946.02.04
|
RIVAROXABAN MYLAN F.C.TAB 10MG/TAB BT X 10 X 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
9,71 |
11,16 |
15,38 |
Mylan Healthcare Ireland Ltd
|
|
32946.03.08
|
RIVAROXABAN MYLAN F.C.TAB 15MG/TAB BT X 28 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
27,33 |
31,42 |
43,30 |
Mylan Healthcare Ireland Ltd
|
|
32946.01.09
|
RIVAROXABAN MYLAN F.C.TAB 2.5MG/TAB BT X 56 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
28,56 |
32,82 |
45,23 |
Mylan Healthcare Ireland Ltd
|
|
32946.04.07
|
RIVAROXABAN MYLAN F.C.TAB 20MG/TAB BT X 28 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
27,33 |
31,42 |
43,30 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.01
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
3,92 |
4,51 |
6,21 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.16
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
3,92 |
4,51 |
6,21 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.03
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
7,84 |
9,01 |
12,41 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.18
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
7,84 |
9,01 |
12,41 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.01
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
5,52 |
6,35 |
8,76 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.16
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
5,52 |
6,35 |
8,76 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.03
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
11,04 |
12,69 |
17,49 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.18
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
11,04 |
12,69 |
17,49 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.01
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.16
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.03
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
13,71 |
15,76 |
21,72 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.18
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
13,71 |
15,76 |
21,72 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.01
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
1,81 |
2,08 |
2,86 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.16
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
1,81 |
2,08 |
2,86 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.03
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
3,41 |
3,93 |
5,41 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.18
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
3,42 |
3,93 |
5,42 |
Mylan Healthcare Ireland Ltd
|
|
31028.02.05
|
SERTRALINE/MYLAN F.C.TAB 100MG/TAB BTx30 (PVC/PVdC-Alu Blister PACKS)
|
|
5,42 |
6,23 |
8,59 |
Mylan Healthcare Ireland Ltd
|
|
31028.01.05
|
SERTRALINE/MYLAN F.C.TAB 50MG/TAB BTx30 (PVC/PVdC-Alu Blister PACKS)
|
|
4,96 |
5,70 |
7,85 |
Mylan Healthcare Ireland Ltd
|
|
31193.01.04
|
SEVELAMER/MYLAN F.C.TAB 800MG/TAB BTx1 HDPE BOTTLE x 180
|
|
45,27 |
52,04 |
66,20 |
Mylan Healthcare Ireland Ltd
|
|
31042.01.17
|
SIMVASTATIN/MYLAN F.C.TAB 10MG/TAB BT x 30 (σε blisters AL/PVC/PVDC) (σε blisters AL/PVC/PVDC)
|
|
1,15 |
1,32 |
1,82 |
Mylan Healthcare Ireland Ltd
|
|
31042.02.17
|
SIMVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx30(BLISTERS AL/PVC/PVdC) AL/PVC/PVdC)
|
|
4,27 |
4,91 |
6,76 |
Mylan Healthcare Ireland Ltd
|
|
31042.03.17
|
SIMVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx30 (BLISTERS ΑL/PVC/PVdC) ΑL/PVC/PVdC)
|
|
4,64 |
5,33 |
7,35 |
Mylan Healthcare Ireland Ltd
|
|
33011.02.05
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+1000)MG/TAB 56 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
11,47 |
13,19 |
18,18 |
Mylan Healthcare Ireland Ltd
|
|
33011.02.06
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+1000)MG/TAB 60 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
12,30 |
14,14 |
19,48 |
Mylan Healthcare Ireland Ltd
|
|
33011.01.05
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+850)MG/TAB 56 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
15,35 |
17,64 |
24,31 |
Mylan Healthcare Ireland Ltd
|
|
33011.01.06
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+850)MG/TAB 60 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
16,45 |
18,90 |
26,04 |
Mylan Healthcare Ireland Ltd
|
|
32315.03.02
|
SITAGLIPTIN/MYLAN F.C.TAB 100MG/TAB BT X 28 F.C.TABS ΣΕ BLISTER OPA/ALU/PVC//ALU
|
|
10,71 |
12,32 |
16,98 |
Mylan Healthcare Ireland Ltd
|
|
32315.02.02
|
SITAGLIPTIN/MYLAN F.C.TAB 50MG/TAB BT X 28 F.C.TABS ΣΕ BLISTER OPA/ALU/PVC//ALU
|
|
8,75 |
10,06 |
13,86 |
Mylan Healthcare Ireland Ltd
|
|
31026.02.03
|
SOTALOL/MYLAN TAB 160MG/TAB ΒΤx30 (BLISTERS)
|
|
2,85 |
3,27 |
4,51 |
Mylan Healthcare Ireland Ltd
|
|
31026.01.03
|
SOTALOL/MYLAN TAB 80MG/TAB ΒΤx30 (BLISTERS)
|
|
1,91 |
2,19 |
3,03 |
Mylan Healthcare Ireland Ltd
|
|
32944.01.02
|
SUGAMMADEX MYLAN INJ.SOL 100MG/ML 10 VIALS X 2 ML
|
|
412,29 |
458,56 |
529,82 |
Mylan Healthcare Ireland Ltd
|
|
32944.01.04
|
SUGAMMADEX MYLAN INJ.SOL 100MG/ML 10 VIALS X 5 ML
|
|
1.051,78 |
1.169,80 |
1.301,99 |
Mylan Healthcare Ireland Ltd
|
|
31016.01.03
|
TAMSULOSIN/MYLAN MOD.R.CA.H 0,4MG/CAP ΒΤ x 20 σε BLISTERS (PVC/PE/PVDC/AL) σε BLISTERS (PVC/PE/PVDC/AL)
|
|
2,52 |
2,90 |
4,00 |
Mylan Healthcare Ireland Ltd
|
|
31646.01.01
|
TIOTROPIUM/MYLAN INHPD.CAP 18MCG/CAP BTx30 caps σε blisters (ALU/ALU/PVC)+ 1 συσκευή NeumoHaler
|
|
12,12 |
13,93 |
19,20 |
Mylan Healthcare Ireland Ltd
|
|
31023.02.07
|
VENLAFAXINE/MYLAN PR.CAP 150MG/CAP BTx30 (PVC/PE/PVDC/Aluminium foil blister)
|
|
5,00 |
5,75 |
7,93 |
Mylan Healthcare Ireland Ltd
|
